Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis

This study is currently recruiting participants.
Verified June 2012 by Yale University
Sponsor:
Collaborator:
Mayo Clinic
Information provided by (Responsible Party):
James Boyer, Yale University
ClinicalTrials.gov Identifier:
NCT01456468
First received: October 14, 2011
Last updated: June 28, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)